Chronic myeloid leukemia

被引:1129
作者
Sawyers, CL
机构
[1] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA
关键词
D O I
10.1056/NEJM199904293401706
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1330 / 1340
页数:11
相关论文
共 100 条
  • [91] Role of interleukin-2 in human hematological malignancies
    Toren, A
    Ackerstein, A
    Slavin, S
    Nagler, A
    [J]. MEDICAL ONCOLOGY, 1995, 12 (03): : 177 - 186
  • [92] TURA S, 1994, NEW ENGL J MED, V330, P820
  • [93] THE MOUSE TYPE-IV C-ABL GENE-PRODUCT IS A NUCLEAR-PROTEIN, AND ACTIVATION OF TRANSFORMING ABILITY IS ASSOCIATED WITH CYTOPLASMIC LOCALIZATION
    VANETTEN, RA
    JACKSON, P
    BALTIMORE, D
    [J]. CELL, 1989, 58 (04) : 669 - 678
  • [94] Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
    vanRhee, F
    Szydlo, RM
    Hermans, J
    Devergie, A
    Frassoni, F
    Arcese, W
    deWitte, T
    Kolb, HJ
    Niederwiser, D
    Jacobsen, N
    Gahrton, G
    Bandini, G
    Carreras, E
    Bacigalupo, A
    Michallet, M
    Ruutu, T
    Reiffers, J
    Goldman, JM
    Apperley, J
    Gratwohl, A
    [J]. BONE MARROW TRANSPLANTATION, 1997, 20 (07) : 553 - 560
  • [95] BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients
    Verfaillie, CM
    Bhatia, R
    Miller, W
    Mortari, F
    Roy, V
    Burger, S
    McCullough, J
    Stieglbauer, K
    Dewald, G
    Heimfeld, S
    Miller, JS
    McGlave, PB
    [J]. BLOOD, 1996, 87 (11) : 4770 - 4779
  • [96] VONCKEN JW, 1992, BLOOD, V79, P1029
  • [97] BCR/ABL P210 AND P190 CAUSE DISTINCT LEUKEMIA IN TRANSGENIC MICE
    VONCKEN, JW
    KAARTINEN, V
    PATTENGALE, PK
    GERMERAAD, WTV
    GROFFEN, J
    HEISTERKAMP, N
    [J]. BLOOD, 1995, 86 (12) : 4603 - 4611
  • [98] ANTI-LEUKEMIC EFFECT OF CHRONIC GRAFT VERSUS HOST-DISEASE - CONTRIBUTION TO IMPROVED SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION
    WEIDEN, PL
    SULLIVAN, KM
    FLOURNOY, N
    STORB, R
    THOMAS, ED
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (25) : 1529 - 1533
  • [99] Identification of the abl- and rasGAP-associated 62 kDa protein as a docking protein, dok
    Yamanashi, Y
    Baltimore, D
    [J]. CELL, 1997, 88 (02) : 205 - 211
  • [100] Zuffa E, 1998, HAEMATOLOGICA, V83, P231